King Oyster, Eryngii · 2006 · Patent
Low relevanceMushroom extracts having anticancer activity
Pleurotus eryngii
Key points
- The invention relates to compositions comprising a mycelium extract from at least one higher Basidiomycetes medicinal mushroom selected from the group consisting of Ganoderma adspersum, Hypsizygus ulmarium, Kuehneromyces mutabilis, Omphalotus olearius, Panus conchatus, Piptoporus betulinus, Pleurotus eryngii, and Trametes zonata, said composition having selective antiproliferative activity on the human chronic myelogenous leukemia K 562 cells and on the human prostate cancer LNCaP cells
- The compositions are useful for treatment of chronic myelogenous leukemia (CML), Ph+ acute lymphoblastic leukemia (ALL), prostate cancer and beta-globin disorders such as sickle cell anemia and beta-thalassemia
From the paper
Abstract
The invention relates to compositions comprising a mycelium extract from at least one higher Basidiomycetes medicinal mushroom selected from the group consisting of Ganoderma adspersum, Hypsizygus ulmarium, Kuehneromyces mutabilis, Omphalotus olearius, Panus conchatus, Piptoporus betulinus, Pleurotus eryngii, and Trametes zonata, said composition having selective antiproliferative activity on the human chronic myelogenous leukemia K 562 cells and on the human prostate cancer LNCaP cells. The compositions are useful for treatment of chronic myelogenous leukemia (CML), Ph+ acute lymphoblastic leukemia (ALL), prostate cancer and beta-globin disorders such as sickle cell anemia and beta-thalassemia.
Citation
MAHAJNA JAMAL A, YASSIN MAJED, WASSER SOLOMON P (2006). Mushroom extracts having anticancer activity.
Open citation